S. Hahnfeld

Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

Uwe Pelzer, Bernhard Opitz, G. Deutschinoff et al. · Journal of Clinical Oncology · 2015 · 262 citations

Phase II Trial of Biweekly Infusional Fluorouracil, Folinic Acid, and Oxaliplatin in Patients With Advanced Gastric Cancer

Salah‐Eddin Al‐Batran, Akin Atmaca, Susanna Hegewisch‐Becker et al. · Journal of Clinical Oncology · 2004 · 184 citations · Full text

Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin’s lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)

Michael Herold, Antina Schulze, Dietger Niederwieser et al. · Journal of Cancer Research and Clinical Oncology · 2005 · 103 citations · Full text

Lymphoid Neoplasia, Oncology, Mantle Cell Lymphoma +8

Results of a Prospective Randomised Open Label Phase III Study Comparing Rituximab Plus Mitoxantrone, Chlorambucile, Prednisolone Chemotherapy (R-MCP) Versus MCP Alone in Untreated Advanced Indolent Non-Hodgkin’s Lymphoma (NHL) and Mantle-Cell-Lymphoma (MCL).

Michael Herold, R. Pasold, Stefanie Srock et al. · Blood · 2004 · 72 citations

A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial

Hanno Riess, Uwe Pelzer, G. Deutschinoff et al. · Journal of Clinical Oncology · 2009 · 70 citations

Surgical Oncology, Conko 004, Cancer Management +19